RepliCel’s product pipeline leverages the unique cellular properties of the hair follicle to develop a portfolio of products that use cells for healing. RepliCel’s cell therapy products are developed to address specific functional cellular deficits which occur as a result of injury, normal aging or genetic predisposition leading to a variety of health conditions.
Future Product Pipeline
RepliCel is investing in research which has the potential to lead to a number of future products including:
• Other chronic tendinopathies (e.g., patellar tendinosis, tennis elbow, golfer’s elbow, rotator cuff)
• Other dermatologic indications (e.g, acne scaring, etc)
• Allogeneic versions of its proven autologous cell therapies